Skip to main content
. 2018 Jul 2;8(42):23990–23995. doi: 10.1039/c8ra04375b

Preliminary evaluation on the anticancer activities of 4d, 4h and 4i on HepG2 cancer cell lines.

Compound 200 μg mL−1 100 μg mL−1 50 μg mL−1
Cell death Cell death Cell death
% Mean ± S.D. % Mean ± S.D. % Mean ± S.D.
4d 67.40 0.325 ± 0.018 30.93 0.691 ± 0.062 16.12 0.838 ± 0.040
4h 59.74 0.402 ± 0.014 30.64 0.693 ± 0.028 20.57 0.794 ± 0.028
4i 79.30 0.209 ± 0.040 70.40 0.474 ± 0.056 44.08 0.559 ± 0.003